Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EHG | Ann: Appendix 3B | 25/05/15 | 0 | 659 | |||
|
|||||||
EHG | Ann: Initial Director's Interest Notice for Ms Khoo | 19/05/15 | 0 | 663 | |||
|
|||||||
EHG | Ann: Initial Director's Interest Notice for Ms Ng | 19/05/15 | 0 | 614 | |||
|
|||||||
EHG | Ann: Initial Director's Interest Notice for Mr Koh | 19/05/15 | 0 | 478 | |||
|
|||||||
EHG | Ann: Final Director's Interest Notice for Mr Urquhart | 19/05/15 | 0 | 571 | |||
|
|||||||
EHG | Ann: Final Director's Interest Notice for Mr Sutton | 19/05/15 | 0 | 434 | |||
|
|||||||
EHG | Ann: Final Director's Interest Notice for Dr Schurmann | 19/05/15 | 0 | 473 | |||
|
|||||||
EHG | Ann: Results of General Meeting | 18/05/15 | 0 | 550 | |||
|
See All Discussions